Update date
31 Dec 2025
Shareable Research Card
This metric view shows PHVS - Pharvaris N.V. liabilities history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported liabilities: €30,180,665. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Dec 2025
Page type
Metric history
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 02 Apr 2026.
Benchmark Context
Pharvaris N.V. sits in the bottom quarter of the current liabilities sample.
Compared with
Compared with 60 companies reporting liabilities in EUR. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Liabilities is up about 28% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Latest period: Q4 2025. Period end: 31 Dec 2025. Units: EUR. Frequency: quarterly.
Liabilities is an SEC-reported metric from company XBRL facts.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare latest available Liabilities levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Pharvaris N.V. appears at rank #54 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Banco Santander, S.A. (san) | €1,754,767,000,000 | Instant - 31 Dec 2025 | Open Banco Santander, S.A. Liabilities |
| 2 | DEUTSCHE BANK AKTIENGESELLSCHAFT (db) | €1,321,219,000,000 | Instant - 30 Jun 2025 | Open DEUTSCHE BANK AKTIENGESELLSCHAFT Liabilities |
| 3 | ING GROEP NV (ing) | €1,004,990,000,000 | Instant - 31 Dec 2025 | Open ING GROEP NV Liabilities |
| 4 | BANCO BILBAO VIZCAYA ARGENTARIA, S.A. (bbva) | €797,778,000,000 | Instant - 31 Dec 2025 | Open BANCO BILBAO VIZCAYA ARGENTARIA, S.A. Liabilities |
| 5 | AEGON LTD. (aeg) | €318,077,000,000 | Instant - 31 Dec 2024 | Open AEGON LTD. Liabilities |
| 6 | ENI SPA (e) | €84,282,000,000 | Instant - 31 Dec 2025 | Open ENI SPA Liabilities |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | €30,180,665 | +€6,566,641 | +28% | 31 Dec 2025 | 20-F | 02 Apr 2026 | 2025 | FY |
| Q2 2025 | €25,474,434 | +€6,397,393 | +34% | 30 Jun 2025 | 6-K | 12 Aug 2025 | 2025 | Q2 |
| Q4 2024 | €23,614,024 | +€8,967,962 | +61% | 31 Dec 2024 | 20-F | 02 Apr 2026 | 2025 | FY |
| Q2 2024 | €19,077,041 | +€3,064,186 | +19% | 30 Jun 2024 | 6-K | 14 Aug 2024 | 2024 | Q2 |
| Q4 2023 | €14,646,062 | -€3,827,891 | -21% | 31 Dec 2023 | 20-F | 07 Apr 2025 | 2024 | FY |
| Q2 2023 | €16,012,855 | -€156,484 | -0.97% | 30 Jun 2023 | 6-K | 07 Aug 2023 | 2023 | Q2 |
| Q4 2022 | €18,473,953 | +€11,336,958 | +159% | 31 Dec 2022 | 20-F | 10 Apr 2024 | 2023 | FY |
| Q2 2022 | €16,169,339 | 30 Jun 2022 | 6-K | 12 Sep 2022 | 2022 | Q2 | ||
| Q4 2021 | €7,136,995 | +€1,823,206 | +34% | 31 Dec 2021 | 20-F | 05 Apr 2023 | 2022 | FY |
| Q4 2020 | €5,313,789 | +€3,389,659 | +176% | 31 Dec 2020 | 20-F | 29 Mar 2022 | 2021 | FY |
| Q4 2019 | €1,924,130 | 31 Dec 2019 | 20-F | 29 Apr 2021 | 2020 | FY |